Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.
Dan Kirby
Axcella Therapeutics
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
93
SSRN CITATIONS
0
CROSSREF CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Efficacy and Tolerability of AXA1125 (Endogenous Metabolic Modulator) in Fatigue-Predominant Long COVID: A Randomized, Double-Blind, Controlled Study
Number of pages: 21
Posted: 14 Feb 2023
Lucy Elizabeth Mary Finnigan
,
Mark Philip Cassar
,
Margaret James Koziel
,
Joel Pradines
,
Hanan Lamlum
,
Karim Azer
, Dan Kirby,
Hugh Montgomery
,
Stefan Neubauer
,
Ladislav Valkovič
and
Betty Raman
University of Oxford - Oxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford - Oxford Centre for Clinical Magnetic Resonance Research (OCMR), Axcella Therapeutics, Axcella Therapeutics, University of Oxford - Oxford Centre for Clinical Magnetic Resonance Research (OCMR), Axcella Therapeutics, Axcella Therapeutics, University College London - Division of Medicine, University of Oxford - Oxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford - Oxford Centre for Clinical Magnetic Resonance Research (OCMR) and University of Oxford - Oxford Centre for Clinical Magnetic Resonance Research (OCMR)
Downloads
93
(535,525)
View PDF
Download
Abstract:
Long COVID, mitochondrial dysfunction, magnetic resonance spectroscopy, therapy
Feedback
